Findings from individual trials suggest additional maternal health benefits with MMS supplementation, such as reduced cortisol and erythropoietin levels in the third trimester (67), and reductions in obstetric complications such as PPROM, postpartum hemorrhage, and puerperal sepsis (68). The gene discussed is EPO; the disease is puerperal disorder.